Wealthy hedge fund executive Scott Bessent – whose confirmation hearing for treasury secretary is slated for Thursday – has ...

WASHINGTON—Tariffs, tax policy and budget deficits look likely to dominate Thursday’s confirmation hearing for Scott Bessent, ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on X4 Pharmaceuticals (XFOR – Research Report) on January 14 and set a price ...

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), ...

Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Nova (NasdaqGS:NVMI) with a Overweight ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) was upgraded by equities research analysts at Cantor Fitzgerald from ...

Here's what to know about the Treasury secretary pick Bessent, who heads into his confirmation hearing and may become the ...

Stock analysts at Cantor Fitzgerald boosted their FY2024 earnings estimates for shares of ADMA Biologics in a research note issued on Tuesday, January 14th. Cantor Fitzgerald analyst K. Kluska now ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

On Wednesday, IMPINJ Inc (PI) stock saw a decline, ending the day at $136.52 which represents a decrease of $-12.79 or -8.57% from the prior close of $149.31. The stock opened at $149 and touched a ...

On Wednesday, X4 Pharmaceuticals Inc (XFOR) stock saw a modest uptick, ending the day at $0.46 which represents no change from the prior close of of $0.46. The stock opened at $0.46 and touched a low ...

InTandem Capital Partners, LLC ("InTandem Capital" or the "Firm"), a healthcare services focused private equity firm, announced today that it has completed a strategic equity investment in Healthfuse ...